Repeated cocaine exposure triggers adaptations in layer 5/6 glutamatergic neurons in the medial prefrontal cortex (mPFC) that promote behavioral sensitization and drug-seeking behavior. While suppression of metabotropic inhibitory signaling has been implicated in these behaviors, underlying mechanisms are unknown. Here, we show that Girk/K IR 3 channels mediate most of the GABA B receptor (GABA B R)-dependent inhibition of layer 5/ 6 pyramidal neurons in the mPFC and that repeated cocaine suppresses this pathway. This adaptation was selective for GABA B R-dependent Girk signaling in layer 5/6 pyramidal neurons of the prelimbic cortex (PrLC) and involved a D 1/5 dopamine receptorand phosphorylation-dependent internalization of GABA B R and Girk channels. Persistent suppression of Girk signaling in layer 5/6 of the dorsal mPFC enhanced cocaine-induced locomotor activity and occluded behavioral sensitization. Thus, the cocaine-induced suppression of GABA B R-Girk signaling in layer 5/6 pyramidal neurons of the prelimbic cortex appears to represent an early adaptation critical for promoting addiction-related behavior.
INTRODUCTION
Drug addiction is marked by subtle yet pervasive disruptions in cognitive function that facilitate its development and contribute to a high rate of relapse in addicts, even after sustained periods of abstinence (Garavan and Hester, 2007) . The prefrontal cortex (PFC) is a critical substrate for many higher-order cognitive functions, including decision making, inhibitory behavior, and processing of reward-related information (Rushworth et al., 2011) . Prolonged exposure to drugs like cocaine promotes structural, physiological, and functional abnormalities within the PFC that compromise these functions.
For example, activity in areas of the PFC of cocaine addicts is decreased during withdrawal but increased during intoxication and exposure to drug-associated cues, the latter of which is associated with feelings of craving (Goldstein and Volkow, 2011) . Lesions of analogous brain regions in the rodent (the medial PFC, or mPFC) facilitate the acquisition of cocaine self-administration (Weissenborn et al., 1997) , while reversal of cocaine-induced prefrontal hypoactivity prevents the development of compulsive drug-seeking behavior (Chen et al., 2013) .
Glutamatergic pyramidal neurons in the deepest layers of the mPFC (layers 5 and 6) are the primary output neurons of the mPFC and represent a major source of excitatory input to the ventral tegmental area (VTA) and nucleus accumbens (NAc). Collectively, these structures comprise the ''reward circuit'' that mediates response to natural reward and drugs of abuse (Koob and Volkow, 2010) . Frontal corticostriatal glutamate projections play a critical role in modulating neurotransmission in the mesocorticolimbic system (Sesack et al., 1989; Taber and Fibiger, 1995) . Moreover, adaptations in glutamate transmission are produced by repeated exposure to cocaine that contributes to the expression of addiction-related behavior. For example, cocaine-induced augmentation of glutamatergic output to the VTA and NAc is critical for the development and expression of behavioral sensitization and reinstatement of drug-seeking behavior (Steketee and Kalivas, 2011) .
Repeated cocaine exposure enhances the responsiveness of mPFC pyramidal neurons to cocaine and cocaine-related stimuli (Sun and Rebec, 2006) . This phenomenon, and the related cocaine-induced augmentation of glutamatergic output from the mPFC to the VTA and NAc, has been linked to adaptations in multiple ion conductances in layer 5/6 mPFC pyramidal neurons (Dong et al., 2005; Nasif et al., 2005a Nasif et al., , 2005b Lu et al., 2010) . Repeated cocaine also weakens signaling mediated by inhibitory G protein-coupled receptors, including the D 2 dopamine receptor (D 2 R) and GABA B receptor (GABA B R), pathways that normally temper the excitability of mPFC pyramidal neurons (Hearing et al., 2012) . Indeed, decreased D 2 R-and GABA B R-dependent modulation of glutamatergic output from the mPFC to the VTA and NAc has been proposed to contribute to the development of cocaine sensitization (Beyer and Steketee, 2002; Jayaram and Steketee, 2004) .
The mechanisms underlying the cocaine-induced suppression of metabotropic inhibitory signaling in the mPFC are unresolved. Reductions in D 2 R availability and expression have been reported in the PFC of human cocaine addicts and in rats following cocaine self-administration (Volkow et al., 1993; Briand et al., 2008) . In contrast, no change in expression level of GABA B R or inhibitory (G i/o ) G proteins (Striplin and Kalivas, 1992; Li et al., 2002) , or functional coupling between GABA B R and G proteins (Kushner and Unterwald, 2001) , has been observed in the mPFC following repeated cocaine exposure. Here, we sought insight into the impact of cocaine on metabotropic inhibitory signaling in layer 5/6 mPFC pyramidal neurons, focusing on the postsynaptic GABA B R signaling pathway.
RESULTS

GABA B R-Dependent Inhibition of Layer 5/6 Pyramidal Neurons of the Prelimbic Cortex
Subregions of the mPFC demonstrate distinct patterns of connectivity and regulate different behavioral functions (Dalley et al., 2004; Vertes, 2004; Marquis et al., 2007) . Increased excitatory output from the dorsal mPFC, which includes the interface between the cingulate (cg) and prelimbic (PrLC) cortices, is crucial for the expression of sensitization and reinstatement of drug-seeking behavior (Tzschentke and Schmidt, 2000; McFarland and Kalivas, 2001; Steketee and Kalivas, 2011; Chen et al., 2013) . Thus, we began by evaluating GABA B Rdependent signaling in layer 5/6 pyramidal neurons in the PrLC ( Figure 1A ). Given the lack of definitive anatomic borders, a small number of neurons in the ventral cingulate (cg) and dorsal infralimbic (ILC) subregions of the mPFC was likely included in the analysis.
(B) Outward current (top trace) evoked by baclofen (200 mM) in a wild-type layer 5/6 PrLC pyramidal neuron (V hold = À60 mV). The baclofeninduced current (I Baclofen ) was associated with a decrease in input resistance (R IN , bottom trace) and was reversed by the GABA B R antagonist CGP54626 (CGP, 2 mM). Scale bars, 50 pA/5 min. (C) Concentration-response curve for I Baclofen in layer 5/6 PrLC pyramidal neurons. Responses to lower concentrations were normalized to the current induced by 200 mM baclofen (Norm. Response %). The EC 50 and Hill slope were 2.1 ± 0.1 mM and 0.54 ± 0.02, respectively (n = 6). (H) Current required to evoke an action potential (AP, Threshold) in neurons from Girk2 -/-mice, as compared to wild-type (WT) (t (23) = 4.1, p < 0.01; n = 10-14/ group). **p < 0.01 versus WT. (I) Current-spike plots for wild-type and Girk2 -/-layer 5/6 PrLC pyramidal neurons (F (10,223) = 2.4, p < 0.01; n = 9-12/group). *p < 0.05 versus wild-type (within current injection group). All data are presented as the mean ± SEM. See Table S1 for electrophysiological properties of layer 5/6 PrLC pyramidal neurons from wild-type and Girk -/-mice, and Figure S1 for Girk1-4 gene expression analysis in the mPFC and analysis of sEPSC data from wild-type and Girk2 -/-mice.
Bath application of a saturating dose of the GABA B R agonist baclofen (200 mM) evoked a robust outward current (I Baclofen ) that showed little desensitization after 10 min of continuous drug application but was reversed by the GABA B R antagonist CGP54626 ( Figure 1B ). I Baclofen was dose dependent, with an EC 50 of 2.1 ± 0.1 mM ( Figure 1C ). I Baclofen was correlated with a decrease in input resistance and it reversed polarity at À88 ± 2 mV (n = 11), consistent with the activation of a K + channel. Indeed, I Baclofen was suppressed by low concentrations of external Ba 2+ (0.3-1 mM) ( Figures 1D and 1E ), pointing to the involvement of an inwardly rectifying K + channel. GABA B Rs activate G protein-gated inwardly rectifying K + (Girk/K IR 3) channels in many neurons, including layer 2/3 mPFC pyramidal cells (Wang et al., 2010) . To test whether Girk channels mediate the GABA B R-dependent inhibition of layer 5/6 PrLC pyramidal neurons, we next compared I Baclofen in slices from wild-type and Girk -/-mice. While Girk ablation had no effect on many parameters of layer 5/6 PrLC pyramidal neurons (Table  S1 available online), I Baclofen was $60% smaller in neurons from Girk -/-mice, with the smallest currents seen in slices from Girk1 -/-and Girk2 -/-mice ( Figures 1D and 1F ). These findings were consistent with RT-PCR data from micropunches containing the mPFC, which showed expression of Girk1, Girk2, and Girk3 in this brain region ( Figure S1A ). Girk1 cannot form functional homomeric Girk channels due to lack of an ER export signal (Ma et al., 2002 Figure 1F ), arguing that compensatory upregulation of Girk3 is not responsible for the residual current. We next asked whether upregulation of Girk4 could explain the residual current measured in slices from Girk1 -/-and Girk2 -/-mice. While sparse Girk4 expression was detected in the deepest layers of the most posterior aspect of the mPFC (Figure S1B), these rare neurons were located outside the region targeted for analysis. Moreover, no difference in Girk4 mRNA levels was observed in mPFC micropunches from wild-type and Girk2/3 -/-mice (Figure S1C) . Thus, the residual I Baclofen seen in Girk -/-mice appears to be Girk independent. The amplitude of the fraction of I Baclofen resistant to Ba 2+ (0.3 mM) was not significantly different in neurons from wildtype (70 ± 5 pA, n = 10) and Girk2 -/-(53 ± 13 pA, n = 6) mice, nor was it different from the residual current in neurons from Girk2 -/-mice measured in the absence of Ba 2+ (79 ± 8 pA;
F (2,25) = 1.98, p = 0.16, n = 12). These findings argue that constitutive Girk ablation did not cause significant alterations in the Girk-independent component of I Baclofen in layer 5/6 PrLC pyramidal neurons. Importantly, the Girk-independent component of I Baclofen was significantly lower when 8Br-cAMP was included in the pipette solution ( Figure 1E ), arguing that this component of I Baclofen is mediated by a cAMP-dependent current.
Girk Channels and the Excitability of Layer 5/6 PrLC Pyramidal Neurons Having established that Girk channels mediate the majority of the direct GABA B R-dependent inhibition of layer 5/6 PrLC pyramidal neurons, we next investigated the contribution of Girk channels to the excitability of these neurons. Neurons from Girk2 -/-mice exhibited a reduced threshold for spiking induced by current injection and an overall leftward shift in the current-spike relationship ( Figures 1G-1I) . Previous work has shown that Girk2 ablation can enhance excitatory neurotransmission in neurons within the VTA and NAc (Arora et al., 2010) . To address the possibility that Girk ablation may enhance excitatory neurotransmission in layer 5/6 PrLC pyramidal neurons, we measured spontaneous EPSCs (sEPSCs) in slices from wild-type and Girk2 -/-mice ( Figures S1D and S1E ). sEPSCs were readily observed in slices from wild-type mice with amplitudes and frequencies consistent with previous report (Wang and Zheng, 2001) . sEPSC frequency, but not amplitude, was elevated significantly in slices from Girk2 -/-mice. Collectively, these data suggest that loss of Girk-dependent signaling leads to enhanced excitability of layer 5/6 PrLC pyramidal neurons.
Cocaine Effects on Layer 5/6 PrLC Pyramidal Neurons
We next asked whether repeated cocaine exposure altered GABA B R-dependent signaling and/or excitability of layer 5/6 PrLC pyramidal neurons (Figure 2 ). Mice were subjected to a 5-day cocaine dosing regimen that induced behavioral sensitization (Figures 2A and 2B ). I Baclofen measured 1-2 days after the last injection was $50% smaller in layer 5/6 PrLC pyramidal neurons from cocaine-treated mice as compared to saline controls ( Figures 2C and 2D ). The cocaine-induced suppression of GABA B R-dependent signaling correlated with a significant depolarizing shift in resting membrane potential (saline: À68 ± 2 mV, n = 9; cocaine: À62 ± 1 mV, n = 11; t (18) = À2.9, p < 0.01) and enhanced excitability of layer 5/6 PrLC pyramidal neurons ( Figures 2E and 2F ). In contrast, a single cocaine injection had no effect on I Baclofen ( Figure 2D ) or excitability (data not shown) of these neurons. The effects of cocaine on GABA B R signaling and excitability of layer 5/6 PrLC pyramidal neurons were surprisingly durable, persisting for up to 6 weeks after the last cocaine injection ( Figures 2G-2I ). In contrast, cocaineinduced effects on sEPSCs frequencies and amplitude were time dependent, with enhanced frequencies observed during early withdrawal and enhanced amplitudes observed after longer withdrawal periods ( Figure S2A -S2D).
Anatomic and Molecular Specificity of the CocaineInduced Adaptation in PrLC Neurons
To examine the anatomic specificity of the cocaine-induced adaptations in GABA B R-dependent signaling and excitability of layer 5/6 PrLC pyramidal neurons, we measured I Baclofen in layer 5/6 pyramidal neurons of the infralimbic (ILC) cortex, layer 2/3 pyramidal neurons in the PrLC, and layer 5/6 pyramidal neurons in primary and secondary motor cortices (M1/M2). Importantly, I Baclofen and excitability measures were unaltered by repeated cocaine exposure in these cortical pyramidal neurons ( Figures  S3A-S3C ). a 2 -adrenergic receptors (a 2 -AR) and D 2/3 dopamine receptors (D 2/3 R) are expressed in PFC pyramidal neurons (Vincent et al., 1993; Aoki et al., 1998) . Thus, we asked whether repeated cocaine suppressed the direct inhibitory effects of these receptor systems on layer 5/6 PrLC pyramidal neurons. Bath application of the a 2 -AR and D 2/3 R agonists guanfacine (20 mM) and quinpirole (20 mM), respectively, evoked small (<50 pA) and transient outward currents in 60% of layer 5/6 PrLC pyramidal neurons (data not shown); no significant differences in current amplitudes were seen between slices from cocaine-and saline-treated animals ( Figures S3D and S3E ).
Increased glutamatergic transmission arising from the mPFC to the VTA and NAc is a hallmark of cocaine-induced sensitization (Steketee and Kalivas, 2011) . To determine whether the cocaine-induced suppression of GABA B R-dependent signaling and enhanced excitability occurred in layer 5/6 PrLC pyramidal neurons projecting to the VTA and/or NAc, we used a retrograde labeling approach. Infusions made into the ventral midbrain targeted the VTA but also reached areas such as the parabrachial pigmented nucleus, paranigral nucleus, and interfasicular nucleus (Figures 3A and 3B) . Consistent with past studies (Gabbott et al., 2005) , Retrobeads injected into the ventral midbrain primarily labeled populations of neurons in layers 5/6 of the PrLC and ILC, with some additional labeling in layer 2/3 and the cingulate region ( Figure 3B ). Infusions made into the NAc targeted primarily the core subregion of the accumbens, as it receives input primarily from the PrLC (Brog et al., 1993) (Figures 3C and 3D) . While injections into the NAc labeled some layer 2/3 neurons, most of labeled neurons were found in layers 5/6 of the PrLC and ILC ( Figure 3D ).
While Retrobead uptake did not alter I Baclofen ( Figure 3F ) or excitability of layer 5/6 PrLC pyramidal cells (data not shown), I Baclofen was notably larger in the retrograde labeling experiments, a distinction attributable to the older age of the mice required for these studies ( Figure 3F ). More importantly, (B) Distance traveled (m) after saline (sal) injection on the second acclimation day and after the first and fifth injections by saline-and cocaine-treated mice (F (2,109) = 37.1, p < 0.001; n = 9-10/group). ***p < 0.001 versus saline-treated mice (within day); ## p < 0.01.
(C) I Baclofen in layer 5/6 PrLC pyramidal neurons from mice given repeated saline (black) or cocaine (gray), measured 1-2 days after the last injection. Scale bars, 50 pA/5 min.
(D) I Baclofen in layer 5/6 PrLC pyramidal neurons measured 1-2 days after a single injection of cocaine (coc) or saline (sal) or after completing the repeated dosing regimen. While a single cocaine injection was without effect on I Baclofen (t (14) = À1.3, p = 0.23; n = 8/group), repeated cocaine treatment suppressed I Baclofen by $50% (t (18) = 4.6, p < 0.001). ***p < 0.001 versus sal.
(E) AP threshold in layer 5/6 PrLC pyramidal neurons, measured 1-2 days after the last injection of saline or cocaine. Repeated cocaine suppressed the AP threshold by $35% (t (24) = 2.4, p < 0.05; n = 12-14/group). A single cocaine injection was without effect on AP threshold (t (14) = 1.5, p = 0.17; n = 5-10/group; data not shown).
(F) Current-spike plots for layer 5/6 PrLC pyramidal neurons from repeated saline-and cocainetreated mice, measured 1-2 days after the final injection (F (8,224) = 5.3; p < 0.05; n = 12-14/group). *p < 0.05 and **p < 0.01, versus sal (within current injection group). Current-spike data were not significantly different in animals treated with a single cocaine or saline injection (F (8,134) = 1.9; p = 0.07; n = 5-10/group; data not shown). (G) I Baclofen in layer 5/6 PrLC pyramidal neurons in saline-and cocaine-treated mice, measured 10-12 days (t (30) = 4.6, p < 0.001; n = 14-18/group) or 28-40 days (t (29) = 3.2, p = 0.004; n = 11-20/group) following the final injection. **p < 0.01 and ***p < 0.001, versus sal. (H) AP threshold in layer 5/6 PrLC pyramidal neurons from repeated saline-and cocaine-treated mice, measured 10-12 days (t (34) = 4.8, p < 0.001; n = 15-21/ group) or 28-40 days (t (38) = 4.8, p = < 0.001; n = 17-23/group) after the last injection. ***p < 0.001 versus sal. (I) Current-spike plots for layer 5/6 PrLC pyramidal neurons from saline-and cocaine-treated mice, measured 10-12 days (F (8,311) = 1.1; p < 0.001; n = 15-17/ group) or 28-40 days (F (11,421) = 4.9; p < 0.001; n = 17-23/group) after the final injection **p < 0.01 and ***p < 0.001, versus sal (within current injection group). All data are presented as the mean ± SEM. See Figure S2 for sEPSC analysis in layer 5/6 PrLC neurons from saline-and cocaine-treated mice.
repeated cocaine significantly reduced I Baclofen in, and augmented the excitability of, layer 5/6 PrLC pyramidal neurons that project to the medial portions (including the VTA) of the ventral midbrain ( Figures 3F-3H ) and NAc ( Figures 3F, 3G , and 3I).
Mechanisms Underlying the Cocaine-Induced Adaptation in PrLC Pyramidal Neurons Systemic cocaine administration increases DA levels in the PFC, exerting both direct and indirect effects on the output of layer 5/6 mPFC pyramidal neurons through activation of D 1 -and D 2 -like receptors in both pyramidal and nonpyramidal cells (Seamans and Yang, 2004; Hyman et al., 2006) . To test whether DA receptor activation mediates the repeated cocaine-induced adaptations in layer 5/6 PrLC pyramidal neurons, we pretreated mice with the D 2/3 R antagonist sulpiride or the D 1/5 R antagonist SCH23390 prior to each cocaine injection (Figure 4 ). Sulpiride pretreatment had no effect on the cocaine-induced suppression of I Baclofen or on the excitability of layer 5/6 PrLC pyramidal neurons. In contrast, SCH23390 pretreatment prevented both the cocaine-induced suppression of I Baclofen and enhanced excitability, indicating that D 1/5 R activation is required for the repeated cocaine-induced suppression of I Baclofen and increased excitability of layer 5/6 PrLC pyramidal neurons. (F) Summary of I Baclofen in layer 5/6 PrLC pyramidal neurons, measured 1-2 days after the last injection. I Baclofen did not differ in Retrobead-positive (Rb+) and negative (RbÀ) layer 5/6 PrLC pyramidal neurons from saline-treated mice (left, t (6) = À1.0, p = 0.4; n = 3-5/group). Cocaine treatment suppressed I Baclofen in layer 5/6 PrLC pyramidal neurons that project to the ventral midbrain (VM, t (20) = 3.9, p < 0.001; n = 10-12/group) and NAc (t (9) = 5.6, p < 0.001; n = 5-6/group). ***p < 0.001 versus sal. (G) AP threshold in layer 5/6 PrLC pyramidal neurons projecting to the VM (t (20) = 2.6, p < 0.05; n = 11/group) and NAc (t (13) = 2.3, p < 0.05; n = 6-9/group) in salineand cocaine-treated mice *p < 0.05 versus sal. (H) Current-spike plots for layer 5/6 PrLC pyramidal neurons projecting to the VM in saline-and cocaine-treated mice (F (13,257) = 4.6, p < 0.001; n = 9-10/group). **p < 0.01 versus sal (within current injection group). (I) Current-spike plots for layer 5/6 PrLC pyramidal neurons projecting to the NAc in saline-and cocaine-treated mice (F (13,209) = 2.8; p < 0.05; n = 6-9/group). **p < 0.01 versus sal (within current injection group). All data are presented as the mean ± SEM. See Figure S3 for data relating to the anatomic and molecular specificity of the cocaine-induced suppression of I Baclofen .
While repeated noncontingent cocaine administration weakens the GABA B R-dependent modulation of excitatory output from the mPFC (Jayaram and Steketee, 2005) , no changes in the functional coupling between GABA B R and G proteins or in the levels of GABA B R or G protein have been reported (Nestler et al., 1990; Striplin and Kalivas, 1992; Kushner and Unterwald, 2001; Li et al., 2002) . To determine whether the cocaine-induced adaptation in GABA B R-dependent signaling is linked to an adaptation in downstream effector(s), we measured I Baclofen in the presence of 0.3 mM Ba 2+ in layer 5/6 PrLC pyramidal neurons from saline-and cocaine-treated wild-type mice. The Ba 2+ -insensitive component of I Baclofen was not significantly different between these groups ( Figure 5A ), indicating that the cocaineinduced suppression of GABA B R-dependent signaling is mediated by a selective suppression of the Girk-dependent component of I Baclofen . Nevertheless, no differences in Girk2 or GABA B R1 subunit mRNA levels ( Figure 5B) , or Girk2 or GABA B R1 total protein levels ( Figure 5C ), were observed in mPFC micropunches from cocaine-and saline-treated mice.
To test whether the cocaine-induced suppression of I Baclofen reflected an internalization of Girk channels, we used quantitative immunoelectron microscopy to compare the subcellular distributions of Girk2 and GABA B R1 in layer 5/6 PrLC pyramidal neurons of cocaine-and saline-treated mice. Consistent with the quantitative immunoblotting data, there was no obvious difference in total Girk2 or GABA B R1 immunolabeling in layer 5/6 PrLC pyramidal neurons from cocaine-treated and salinetreated mice. In samples from saline-treated controls, Girk2 and GABA B R1 immunoparticles were found mainly in the extrasynaptic plasma membrane of dendritic shafts and spines, with $35% of immunolabeling observed at intracellular sites ( Figures  5D and 5E ; Figure S4 ). In samples from cocaine-treated mice, the density of Girk2 and GABA B R1 immunolabeling in dendritic and spine membranes was significantly reduced, with a corresponding increase in intracellular labeling ( Figures 5D and 5E ). Thus, repeated cocaine treatment triggered a redistribution of (D) Plasma membrane-associated immunogold particle density for Girk2 and GABA B R1 (BR1) in layer 5/6 PrLC pyramidal neuron spines (left, Girk2: t (118) = 4.4, p < 0.001; GABA B R1: t (118) = 4.5, p < 0.001; n = 60/group) and dendrites (right, Girk2: t (118) = 4.6, p < 0.001; GABA B R1: t = 4.4, p < 0.001; n = 60/group) from saline-and cocaine-treated mice (n = 6/group). ***p < 0.001 coc versus sal. (E) Distribution of Girk2 immunogold particles at the plasma membrane (PM) and intracellular (intra) sites, expressed as a percentage of total particles analyzed in spines and dendrites of layer 5/6 PrLC pyramidal neurons from saline-and cocaine-treated mice (n = 420-430 total particles/group). The redistribution of GABA B R1 was comparable to that seen for Girk2 (data not shown). **p < 0.01 intra-sal versus PM-sal; ## p < 0.01 intra-coc versus PM-coc.
All data are presented as the mean ± SEM. See Figure S4 for immunoelectron micrographs from which data in (D) and (E) were extracted.
Girk2 and GABA B R1 from the dendritic membrane to intracellular sites in layer 5/6 PrLC pyramidal neurons. Surface trafficking of GABA B R and Girk channels is regulated by phosphorylation-dependent mechanisms. For example, phosphorylation of Ser-9 on Girk2 promotes internalization of Girk2-containing channels, while dephosphorylation of Ser-783 on GABA B R2 is associated with reduced surface expression of the GABA B R (Chung et al., 2009; Terunuma et al., 2010; Padgett et al., 2012) . Using phosphospecific antibodies, we next evaluated whether the phosphorylation of Girk2(Ser-9) or GABA B R2(Ser-783) was altered by repeated cocaine in mPFC tissue punches from saline-and cocaine-treated mice. While no differences in the level of phosphorylated Girk2(Ser-9) were detected between groups, repeated cocaine treatment correlated with a significant reduction in the phosphorylation of GABA B R2(Ser-783) ( Figure 6A ).
As phosphatase PP2A can dephosphorylate GABA B R2(pSer-783) (Terunuma et al., 2010) , we next evaluated the effect of acute intracellular application of okadaic acid (OA; 100 nM) on I Baclofen and excitability in layer 5/6 PrLC pyramidal neurons ( Figures 6B-6E) . In saline-injected mice, there was no significant effect of OA on I Baclofen or excitability, suggesting that tonic phosphatase activity does not regulate GABA B R-dependent signaling or excitability in these neurons. In cocaine-treated animals, however, OA normalized I Baclofen and excitability in layer 5/6 PrLC pyramidal neurons, suggesting that the redistribution of GABA B R and Girk2 from the surface membrane to intracellular sites is linked to the dephosphorylation of GABA B R2.
Girk Signaling in the mPFC and Behavioral Sensitization
Enhanced glutamatergic output from the prelimbic subregion of the mPFC contributes to the development of cocaine-induced behavioral sensitization (Steketee and Kalivas, 2011) . Data presented above suggest that the suppression of Girk signaling in layer 5/6 PrLC pyramidal neurons contributes, at least in part, to the cocaine-induced increase in excitability of these neurons. To test whether the cocaine-induced suppression of Girk signaling in the mPFC contributes to the development of behavioral sensitization, we used a viral RNAi strategy to persistently suppress Girk signaling in layer 5/6 of the dorsal aspect of the mPFC. We infused bilaterally a mixture of lentiviruses harboring shRNAs for Girk1 and Girk2 (Girk1/2-LV), or a GFP-non-target control, into deep cortical layers of the dorsal mPFC of wildtype mice ( Figure 7A ; Figure S5 ). Girk2 protein levels were significantly lower in mPFC micropunches from Girk1/2-LV mice as compared to the control group ( Figure 7B ). Mice given intramPFC Girk1/2-LV displayed normal motor activity during habituation (data not shown) and in response to saline injection but showed elevated responses to the first three cocaine injections ( Figure 7C ). Importantly, cocaine-induced activity levels for Girk1/2-LV-treated mice did not differ between the first and fifth injections and were indistinguishable from those exhibited by control animals after their fifth cocaine injection. In contrast, control animals displayed a progressive increase in cocaine-induced motor activity over the five injections. Collectively, these data suggest that the persistent suppression of Girk signaling in layer 5/6 of the dorsal mPFC can presensitize mice to the motor-stimulatory effect of cocaine.
DISCUSSION
Repeated cocaine exposure increases the excitability of layer 5/6 mPFC pyramidal neurons, making them more responsive to cocaine and cocaine-associated cues (Sun and Rebec,
I
Baclofen ( and GABA B R2(Ser-783) (pSer783, right) in mPFC micropunches from repeated saline and cocainetreated mice, measured 1-2 days after the final injection. Bottom: quantification of Girk2(pSer-9) (t (6) = À0.85, p = 0.43; n = 4/group) and GABA B R2(pSer-783) (t (10) = 3.9, p = 0.003; n = 6/ group) with normalization to the total level of Girk2 and GABA B R2 (BR2), respectively. **p < 0.01 versus sal. (E) Current-spike plots for layer 5/6 PrLC pyramidal neurons from saline-and cocaine-treated mice, measured with and without OA in the pipette solution (F (24,224) = 4.7, p < 0.001; n = 6-8/group). *p < 0.05, **p < 0.01, ***p < 0.001, versus sal and coc/OA. All data are presented as the mean ± SEM.
2006). One consequence of these adaptations is enhanced glutamatergic output to the VTA and NAc, which is critical for the development and expression of addictive behaviors such as sensitization (Jayaram and Steketee, 2004; Steketee and Kalivas, 2011) . GABA B R-dependent signaling plays a fundamental role in regulating mPFC glutamatergic output to limbic structures (Jayaram and Steketee, 2004; Harte and O'Connor, 2005) , and repeated cocaine exposure reduces GABA B R-dependent inhibitory influences in the mPFC (Jayaram and Steketee, 2004; Steketee and Beyer, 2005) . Here, we show that repeated cocaine suppresses GABA B R-Girk signaling in layer 5/6 PrLC pyramidal neurons in a durable and specific manner, contributing to the enhanced excitability of neurons implicated in the development of addiction-related behavior. Pharmacologic and genetic approaches revealed that most ($70%) of the direct inhibitory effect of GABA B R activation in layer 5/6 PrLC pyramidal neurons is attributable to Girk channel activation. Importantly, repeated cocaine selectively suppressed this dominant (Girk-dependent) component of I Baclofen . The Girkindependent component of the GABA B R-induced current was suppressed by 8Br-cAMP, arguing that this conductance is modulated via the Gi/o-dependent inhibition of adenylyl cyclase activity and subsequent decline in intracellular cAMP. In light of the 8Br-cAMP sensitivity and recent studies (Deng et al., 2009; Sandoz et al., 2012) , the non-Girk component of I Baclofen may be mediated by a two-pore domain Trek K + channel. Modulation of HCN channels may also play a role, however, as they are found in layer 5/6 pyramidal neurons (Kase and Imoto, 2012) . DA input from the VTA influences the response of the mPFC to reward (Wolf and Roth, 1987) . We found that D 1/5 R antagonism prevented the cocaine-induced suppression of GABA B R-dependent signaling and increased excitability of layer 5/6 PrLC pyramidal neurons. Repeated cocaine exposure has been shown to upregulate cAMP signaling mPFC pyramidal neurons (Dong et al., 2005) and reduce D 2 R-dependent inhibition in layer 5/6 mPFC pyramidal neurons (Nogueira et al., 2006) , the latter of which would further contribute to enhanced cAMP signaling. Thus, the cocaine-induced, D 1/5 R-dependent suppression of GABA B R-Girk signaling in layer 5/6 PrLC pyramidal neurons seen here may reflect enhanced activation of cAMP-dependent signaling. Indeed, Szulczyk and colleagues demonstrated that a Girk-like channel in mPFC pyramidal neurons was inhibited both by D 1 R activation and cAMP (Witkowski et al., 2008 (Witkowski et al., , 2012 .
While D 1/5 R activation in PrLC pyramidal neurons may trigger the cocaine-induced suppression of GABA B R-Girk signaling, D 1/5 Rs were blocked globally in our study. Importantly, activation of D 5 R signaling in the VTA was linked to the increase in excitatory transmission seen in VTA DA neurons triggered by cocaine (Argilli et al., 2008) . This form of plasticity occurs following a single exposure to cocaine and facilitates a shift in the threshold for induction of plasticity in downstream targets of the VTA, including the mPFC (Mameli et al., 2009) . Thus, if D 1/5 R antagonist pretreatment prevented excitatory adaptations in VTA DA neurons in our study, it may also have blocked initiation of downstream adaptations in the mPFC, including the suppression of GABA B R-Girk signaling, that normally occur following repeated cocaine exposure.
Local GABA interneurons and GABA-containing projection neurons arising from the VTA are major sources of GABA in the mPFC (Kawaguchi, 1993; Retaux et al., 1993; Carr and Sesack, 2000) . Recently, Slesinger and colleagues demonstrated that acute cocaine and methamphetamine exposure depressed GABA B R-Girk signaling in VTA GABA neurons in a D 1/5 R-dependent manner (Padgett et al., 2012) . Repeated cocaine exposure also suppressed the influence of D 2 R on GABA interneurons of the mPFC, leaving an unopposed D 1 R-mediated enhancement of local GABA signaling (Kroener and Lavin, 2010) . Together, these observations provide reasonable explanations for the elevated extracellular GABA levels seen in the mPFC of cocaine-sensitized rats Steketee, 2005, 2006) and suggest the intriguing possibility that the cocaine-induced suppression of GABA B R-dependent signaling in layer 5/6 PrLC pyramidal neurons reflects a desensitization of GABA B R-Girk signaling triggered by elevated GABA transmission.
Activation of the PrLC and its projections to the NAc core is necessary for the development and expression of sensitization, as well as initiating and reinstating cocaine-seeking behavior in self-administering rats (Pierce et al., 1998; Tzschentke and Schmidt, 2000; Kalivas and O'Brien, 2008) . Activation of the ILC and its projections to the shell region of the NAc is responsible for inhibiting drug seeking during extinction training (Peters , 2008) . Akin to this functional dichotomy, we demonstrate that while layer 5/6 pyramidal neurons in PrLC and ILC subregions of the mPFC showed robust GABA B R-Girk responses, repeated cocaine exposure suppressed GABA B R-Girk signaling selectively in the PrLC. Moreover, persistent suppression of Girk signaling, primarily targeting the dorsal aspect of the mPFC, was sufficient to potentiate acute cocaine-induced motor activity and prevent the augmentation of activity seen with repeated cocaine dosing. These data support the contention that the cocaineinduced suppression of Girk signaling contributes to increased excitatory output from layer 5/6 PrLC pyramidal neurons that are important for key aspects of addiction-related behavior, including sensitization.
We reported previously that excitatory neurotransmission was elevated in VTA DA neurons from Girk1 -/-and Girk2 -/-mice, observations that correlated with elevated levels of synaptic AMPA receptors (Arora et al., 2010) . Similar adaptations were observed in NAc medium spiny neurons (Arora et al., 2010) . As Girk1 is not expressed in VTA DA neurons, and neither Girk1 nor Girk2 are abundantly expressed in the NAc (Karschin et al., 1996) , these adaptations are likely secondary to the loss of Girk signaling in an afferent glutamatergic neuron population. Our work here shows that Girk channels containing Girk1 and Girk2 temper the excitability of layer 5/6 PrLC pyramidal neurons, a major source of glutamate to the VTA and NAc. Thus, Girk signaling in layer 5/6 PrLC pyramidal neurons may represent a barrierlowered by cocaine-to persistent adaptations in excitatory neurotransmission in the VTA and/or NAc that promotes addiction-related behaviors associated with drug seeking and relapse.
EXPERIMENTAL PROCEDURES Animals
Animal use was approved by the Institutional Animal Care and Use Committee at the University of Minnesota. Girk -/-mice have been used extensively to characterize Girk contributions to metabotropic inhibitory signaling (e.g., Koyrakh et al., 2005) . The Tg(Kcnj5-EGFP)49Gsat line was generated as part of the GENSAT project and bred onsite. Male C57BL/6J mice were purchased from The Jackson Laboratory for all studies involving cocaine.
Drugs
Cocaine hydrochloride, baclofen, sulpiride, SCH23390, guanfacine, quinpirole, and barium chloride were purchased from Sigma. 8-Bromoadenosine 3 0 ,5 0 -cyclic monophosphate (8Br-cAMP) and CGP54626 were purchased from Tocris. Okadaic acid was purchased from MP Biomedicals.
Motor Activity
Activity studies were performed in open-field activity chambers as described (Arora et al., 2011) . Animals were acclimated to testing room, handling, and chambers for 3 days prior to repeated cocaine or saline treatment. Subjects received five injections of cocaine (15 mg/kg, intraperitoneally [i.p.]) or saline over a 5-7 day period. For DA receptor antagonist experiments, mice were pretreated with saline, SCH23390, or sulpiride 30 min prior to each saline or cocaine injection.
Electrophysiology
Coronal slices (300 mm) containing the mPFC were prepared from wild-type and Girk -/-mice (4-6 weeks), and repeated saline-or cocaine-treated C57BL/6J mice (5-10 weeks), in an ice-cold solution containing 1.9 mM KCl, 1.2 mM Na 2 HPO 4 , 33 mM NaHCO 3 , 6 mM MgCl 2 , 0.5 mM CaCl 2 , 10 mM glucose, 0.4 mM ascorbic acid, and 200 mM sucrose, bubbled with 95% O 2 /5% CO 2 . Slices were transferred to prewarmed (32 C-35 C) ACSF containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM Na 2 HPO 4 , 25 mM NaHCO 3 , 4 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose, and 0.4 mM ascorbic acid (pH 7.3-7.4) and gradually acclimated to room temperature over the course of R1 hr. Slices were transferred to a recording chamber and superfused with oxygenated ACSF containing 125 mM NaCl, 2.5 mM KCl, 25 mM NaHCO 3 , 1.3 mM MgCl 2 , 2.0 mM CaCl 2 , 10 mM glucose, and 0.4 mM ascorbic acid (pH 7.3-7.4) at a flow rate of 2-2.5 ml/min. Bath and chamber temperatures were maintained at 29 C-30 C. Borosilicate (3-5 MU) electrodes were filled with 140 mM K-gluconate, 2 mM MgCl 2 , 1.1 mM EGTA, 5 mM HEPES, 2 mM Na 2 -ATP, 0.3 mM Na-GTP, and 5 mM phosphocreatine (pH 7.4). The predicted E K for these conditions was À105 mV. In some experiments, okadaic acid (100 nM) was added to the pipette. Currents, resistances, and potentials were measured using a Multiclamp 700A amplifier and pCLAMP v.9 software (Molecular Devices) and stored on hard disk. All measured and command potentials factored in a junction potential of À15 mV predicted using JPCalc software (Molecular Devices). Pyramidal neurons in layer 5/6 were identified based on a pyramidal-shaped soma, a long apical dendrite extending toward superficial cortical layers, a resting membrane potential %À60 mV, lack of spontaneous activity, and an apparent capacitance of R100 pF (Connors and Gutnick, 1990; Yang et al., 1996; Kawaguchi and Kubota, 1997) . For rheobase assessments, cells were held in current-clamp mode and given 1 s current pulses beginning at À60 pA and progressing to 200 pA in 20 pA increments. Agonist-induced changes in holding current were measured at a holding potential (V hold ) of À60 mV; holding current, input resistance, and series resistance values were monitored during experiments by tracking responses to periodic (0.2 Hz) voltage steps (À5 mV, 800 ms). Only experiments with stable (<20% variation) and low series resistances (<20 MU) were analyzed.
Retrograde Labeling
Male C57BL/6J mice (6-8 weeks) were anesthetized with ketamine (100 mg/kg, i.p)/xylazine (10 mg/kg, i.p) and placed in a stereotaxic device (David Kopf Instruments). A 5 ml Hamilton syringe was placed into the VTA (from bregma: +3.08 mm AP, ± 0.5 mm ML; from ventral skull surface: À3.7 mm DV) or the NAc (from bregma: +1.1 mm AP, ± 1.0 mm ML; from ventral skull surface: À3.8 mm DV) and remained in place for 2 min prior to bilateral infusion (0.3-0.4 ml, 0.1 ml/min) of Retrobeads (LumaFlour) using an UltraMicroPump with SYS-Micro4 controller (World Precision Instruments). After a 10 min delay to reduce solution backflow along the infusion track, the syringe was removed. Repeated cocaine treatment began after a suitable period to allow for retrograde transport of Retrobeads from the VTA (18-21 days) or NAc (10-15 days) to the mPFC. Retrobead injection sites were determined by serial sectioning and staining with green Nissl (NeuroTrace 500/525, Molecular Probes). Mice with improper targeting or significant bead contamination outside target areas were excluded from analysis.
qRT-PCR mPFC punches (2 mm diameter, 2 mm thick) were taken from male C57BL/6J mice (5-7 weeks), 1 day after the final cocaine or saline injection. Quantitative analysis of GABA B R1 and Girk2 mRNA levels was performed as described (Arora et al., 2011) .
Immunoblotting mPFC punches (2 mm diameter, 2 mm thick) were sonicated in 1% SDS lysis buffer containing a Halt phosphatase and protease inhibitor cocktail (Thermo Fisher Scientific), heated at 85 C for 10 min, and centrifuged at 4 C for 20 min at 16,000 3 g. Protein samples (40 mg) were separated by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked in 5% milk/Tris-buffered saline (TBS), incubated overnight at 4 C with antibodies against Girk2 (1:200; Alomone Labs), Girk2(pSer-9) (1:200; Chung et al., 2009) , GABA B R1 (1:500; Kulik et al., 2003) , GABA B R2 (1:10; NeuroMab), GABA B R2(pSer-783) (1:200; PhosphoSolutions), or b-actin (1:10,000; Abcam), diluted in 5% milk/TBS/0.1% Tween-20 or 1% milk/TBS/0.1% Tween-20. Membranes were washed with TBS/0.1% Tween-20 or 1% milk/TBS/0.1% Tween-20 and incubated with donkey anti-mouse (926-32212; 1:1,000-5,000; LI-COR Biosciences) or anti-rabbit (926-68072; 1:5,000; LI-COR) secondary antibodies. Blots were developed using the Odyssey infrared imaging system (LI-COR) and an integrated density of each band was measured using ImageJ software (NIH).
Quantitative Immunoelectron Microscopy
The subcellular distribution of Girk2 and GABA B R1 was measured using pre-embedding immunoelectron microscopy and quantitative analysis approaches, as described (Arora et al., 2011) .
Lentiviral Suppression of Girk Signaling pLKO.1-puro-CMV-eGFP-based shRNA constructs specific for Girk1 (TRCN0000069733, Sigma) and Girk2 (TRCN0000069814) were identified based on their ability to suppress target expression in a heterologous system (data not shown). These constructs, and a nontarget control, were used to generate high-titer (>3 3 10 9 TU/ml) lentiviral stocks. Male C57BL/6J mice (5-7 weeks) were anesthetized and secured in a stereotaxic device. Girk1 and Girk2 knockdown lentiviral stocks were mixed, loaded into a 5 ml Hamilton syringe, and lowered into the mPFC. Two infusions (0.4 ml/infusion site; 0.2 ml/min) were made to ensure sufficient coverage in the mPFC (from bregma: +1.9 mm AP, ± 0.3 mm ML; from ventral skull surface: À1.2/À1.5 mm DV). After each infusion, the syringe was left in place for 5 min to reduce backflow. Mice began the repeated cocaine regimen 21-24 days after viral infusion. Motor activity data were analyzed if bilateral eGFP expression was detected in layer 5/6 of the dorsal portion of mPFC.
Data Analysis
Statistical analysis was performed using SigmaPlot (Systat Software). Motor activity data were analyzed using one-way, two-way, and two-way repeated-measures (RM) ANOVA, as appropriate. sEPSCs were analyzed using Minianalysis software using a 20 pA detection threshold (Synaptosoft). I Baclofen and current injection data were analyzed with Student's t test or one-way ANOVA, while current-spike relationships were analyzed with twoway RM ANOVA. Immunoelectron microscopy data were analyzed using a Mann-Whitney rank-sum test. Student Newman-Keuls post hoc test was used for pairwise comparisons as appropriate. The threshold for statistical significance was p < 0.05. 
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